| Financial Year |
March 31 2023 |
| Monetary Funds |
10,913,163.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
208,878,696.82 |
| Advances to Suppliers |
14,050,090.45 |
| Other Receivables |
2,241,008.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,799,912.76 |
| Total Current Assets |
522,597,117.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,397,933.49 |
| Investment Properties |
-- |
| Fixed Assetes |
12,331.29 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
5,154,494.08 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
188,965,459.68 |
| Total Assets |
711,562,577.02 |
| Short-Term Loans |
44,800,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
261,384,548.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
592,474.24 |
| Taxes Payable |
2,934,823.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,467,650.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
50,021,329.12 |
| Sub-Total of Current Liabilities |
391,347,614.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
391,347,614.34 |
| Paid-In Capital(Or Share Stock) |
425,373,000.00 |
| Capital Surplus |
147,565,569.68 |
| Surplus Reserve |
48,812,206.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-295,385,823.80 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
320,214,962.68 |
| Owner's Equity（Stockholder's Equity） |
320,214,962.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
711,562,577.02 |
